Head to Head Comparison: Axe Compute (NASDAQ:AGPU) versus CoreWeave (NASDAQ:CRWV)

Axe Compute (NASDAQ:AGPU) and CoreWeave (NASDAQ:CRWV) are both technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Profitability

This table compares Axe Compute and CoreWeave’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Axe Compute	-7,769.61%	-1,606.56%	-355.39%
CoreWeave	-25.41%	-47.95%	-3.79%

Institutional and Insider Ownership

9.0% of Axe Compute shares are held by institutional investors. 1.2% of Axe Compute shares are held by company insiders. Comparatively, 24.2% of CoreWeave shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Axe Compute has a beta of 3.84, suggesting that its share price is 284% more volatile than the S&P 500. Comparatively, CoreWeave has a beta of 7.71, suggesting that its share price is 671% more volatile than the S&P 500.

Earnings and Valuation

This table compares Axe Compute and CoreWeave”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Axe Compute	$120,000.00	730.17	-$233.10 million	($5.75)	-1.31
CoreWeave	$5.13 billion	4.81	-$1.17 billion	($3.65)	-14.72

Axe Compute has higher earnings, but lower revenue than CoreWeave. CoreWeave is trading at a lower price-to-earnings ratio than Axe Compute, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Axe Compute and CoreWeave, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Axe Compute	1	0	0	1	2.50
CoreWeave	4	7	27	0	2.61

CoreWeave has a consensus price target of $130.24, suggesting a potential upside of 142.36%. Given CoreWeave’s stronger consensus rating and higher possible upside, analysts plainly believe CoreWeave is more favorable than Axe Compute.

Summary

CoreWeave beats Axe Compute on 10 of the 14 factors compared between the two stocks.

About Axe Compute

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient’s body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

About CoreWeave

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.